Constance Finley is founder and CEO of Constance Therapeutics, a California Proposition 215 compliant medicinal cannabis company inspired by her personal experience with medicinal cannabis as a means to manage symptoms caused by a rare autoimmune disease. Constance Therapeutics works alongside healthcare professionals to provide patients with the best possible treatment options, including high-quality, whole-plant cannabis oils developed through a stringent, science-informed and patent-pending extraction method. Finley sits on various advisory boards, including an assignment to the Scientific Advisory Board for CannaTech. Prior to Constance Therapeutics, Finley was founder and CEO of Housing Allies, Inc., where she pioneered the use of tax credits to create low-income housing for the working poor and ill. Finley holds a Master of Arts in Clinical Psychology from the University of San Francisco and a Bachelor of Arts in Eastern Studies and Psychology from Lone Mountain College in San Francisco.